Amneal Pharma Hiring Drive ARD, Regulatory Affairs, Publishing, and Labelling Experts (Ahmedabad)

Amneal Pharmaceuticals, a global leader in high-quality generic medicines and complex dosage forms, is actively recruiting experienced professionals for multiple specialized roles in its Analytical Research & Development (ARD), Regulatory Affairs (RA), Regulatory Publishing, and Labelling teams. All open positions are on-site at the company’s facility in Ahmedabad.

The ideal candidates will have specific experience supporting the company’s diverse portfolio, particularly focusing on the demanding US Market.

Application Submission

Interested candidates must submit their updated CVs via email to: kavitriy@amneal.com by the Last Date: 30th November 2025.

Detailed Vacancy Breakdown

1. Analytical R&D (ARD)

Amneal is hiring for both Injectable and Oral Solid Dosage (OSD) domains:

ARD Injectable: Positions for Executive / Senior Executive require an M.Sc. / M.Pharm degree and 2 to 7 years of experience. Injectable and complex Injectable experience is mandatory.
ARD OSD: Positions for Executive / Senior Executive require an M.Sc. / M.Pharm degree and 3 to 7 years of experience. Required skills include expertise in GLP Position, GC-MS Position, and Extractable & Leachable Position.

2. Regulatory Affairs (RA)

Post: Senior Executive – Deputy Manager
Qualification: M.Pharm
Experience: 4 to 10 years
Focus: Injectable and Complex Injectable experience for the Pre Approval Team (PAT) for the US Market is mandatory.

3. Regulatory Operations & Labelling

Regulatory Publishing: Positions for Executive / Senior Executive require a B.Pharm / M.Pharm degree and 2 to 7 years of experience. US Market experience and e-CTD exposure is mandatory.
Labelling: Positions for Executive / Senior Executive require a B. Pharm / M.Pharm degree and 3 to 7 years of experience. US Labelling experience is mandatory, with the company specifically seeking candidates with core labelling experience.

All roles offer a challenging opportunity to contribute to a rapidly expanding global pharmaceutical portfolio.